The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients

Figure 3

Diagnostic value of PIVKA-II for AFP-negative HCC patients. ROC curves of PIVKA-II for diagnosis of HCC (a) and early stage HCC (b) in AFP-negative HCC patients; the AUC were 0.88 and 0.81, respectively.

(a)

(b)